Ganot Ilan 4
4 · Solid Biosciences Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Ganot Ilan
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-03+2,994→ 18,331 total(indirect: By Spouse) - Sale
Common Stock
2026-01-05$5.43/sh−1,053$5,718→ 17,278 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Units
2026-01-03−2,994→ 2,994 total(indirect: By Spouse)→ Common Stock (2,994 underlying)
Holdings
- 95,413
Common Stock
- 19,394(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]Restricted stock units convert to common stock on a one-for-one basis.
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot.
- [F3]Represents 91,371 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
- [F4]Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
- [F5]On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.